|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|
| Revenues: | ||||
| Patient and net professional fees | ||||
| Contracted marketing revenues | ||||
| Factoring revenues | ||||
| Total revenues | ||||
| Salaries and benefits | ||||
| Operating Expense | ||||
| Corporate Segment | ||||
| Drugs and supplies | ||||
| General and administrative | ||||
| Operating Expense | ||||
| Corporate Segment | ||||
| Bad debt expense (recovery), net | ||||
| Operating Expense | ||||
| Total bad debt expense (recovery), net | ||||
| Legal expenses | ||||
| Depreciation and amortization | ||||
| Operating Expense | ||||
| Corporate Segment | ||||
| Operating Expenses | ||||
| Operating Expense | ||||
| Corporate Segment | ||||
| Income from operations | ||||
| Other expense (income): | ||||
| Change in fair value of warrant and stock option derivative liabilities | ||||
| Interest expense | ||||
| Bargain purchase gain | ||||
| Other (income) expense, net | ||||
| Total other expense (income) | ||||
| Income before income taxes and noncontrolling interests | ||||
| Income tax expense | ||||
| Income tax benefit | ||||
| Income tax expense (benefit) | ||||
| Net income | ||||
| Net income attributable to noncontrolling interests | ||||
| Net income attributable to Nobilis Health Corp. | ||||
| Net income per basic common share (in dollars per share) | ||||
| Net income per fully diluted common share (treasury stock method) (in dollars per share) | ||||
| Net income per fully diluted common share (if converted method) (in dollars per share) | ||||
| Weighted average shares outstanding (basic) (in shares) | ||||
| Weighted average shares outstanding (fully diluted - treasury stock method) (in shares) | ||||
| Weighted average shares outstanding (fully diluted - if converted method) (in shares) | ||||
Loading...